Trials / Completed
CompletedNCT00550433
Study Evaluating Bazedoxifene/CE in Postmenopausal Women
An Open-Label, Single-Dose, Randomized, 4-Period, Crossover, Bioequivalence Study of Clinical and Commercial Formulations of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- Female
- Age
- 35 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this clinical trial is to study the blood levels of a drug (conjugated estrogens) in the body from one dosage form compared to another. The four formulations of the study drug that eligible participants will receive will contain the same amounts of the same medications. In addition, information will also be obtained regarding the safety and tolerability of the formulations given to healthy postmenopausal women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bazedoxifene/Conjugated Estrogens |
Timeline
- Start date
- 2007-09-01
- Completion
- 2007-11-01
- First posted
- 2007-10-29
- Last updated
- 2008-01-16
Source: ClinicalTrials.gov record NCT00550433. Inclusion in this directory is not an endorsement.